Welcome to LookChem.com Sign In|Join Free

CAS

  • or

749927-93-3

Post Buying Request

749927-93-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

749927-93-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 749927-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,9,2 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 749927-93:
(8*7)+(7*4)+(6*9)+(5*9)+(4*2)+(3*7)+(2*9)+(1*3)=233
233 % 10 = 3
So 749927-93-3 is a valid CAS Registry Number.

749927-93-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-methoxy-N-methyl-3-(4-methoxyphenyl)propionamide

1.2 Other means of identification

Product number -
Other names N-methoxy-3-(4-methoxyphenyl)-N-methylpropanamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:749927-93-3 SDS

749927-93-3Relevant articles and documents

Divergent reactivity of phenol- and anisole-tethered donor-acceptor α-diazoketones

Clarke, Aimee K.,Unsworth, William P.,Taylor, Richard J.K.

, p. 5374 - 5382 (2018/03/29)

The first study of the divergent reactivity of phenol/anisole-tethered donor-acceptor α-diazoketones is described. Four distinct product classes were shown to be accessible from closely related α-diazoketone precursors, with the reaction outcome dependent

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

-

Page/Page column 27, (2008/06/13)

The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 749927-93-3